{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:49:00Z","timestamp":1793659740038,"version":"4.5.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The purpose of this investigation was to evaluate the morphology and physiological function of the meibomian glands between type 2 diabetics with dry eye disease (DED) and control subjects. Doing so will help to better reveal the pathologic mechanisms of meibomian gland dysfunction (MGD) and DED in type 2 diabetes mellitus (T2DM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ninety subjects were divided into the following four groups: DM-DED group: T2DM patients with DED (<jats:italic>n<\/jats:italic>\u2009=\u200930); DM control group: DM patients without DED (<jats:italic>n<\/jats:italic>\u2009=\u200918); DED group: DED patients without DM (<jats:italic>n<\/jats:italic>\u2009=\u200926); and normal control group: normal subjects (<jats:italic>n<\/jats:italic>\u2009=\u200916). All participants administered the ocular surface disease index (OSDI) questionnaire, tear meniscus height (TMH), noninvasive Keratograph tear film break-up time (NIKBUT), Schirmer I test (SIT), corneal fluorescein staining (CFS), eyelid margin abnormality examinations, meibum quality and meibomian gland (MG) dropout evaluations. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The percentage of MG dropout in the upper and lower lids was significantly higher in the DM-DED group than the DED group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 or <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). However, there was no significant difference in other MG parameters between these two groups. Oppositely, Significant difference was observed in all of MG parameters except MG dropout in the lower lids comparing DM group with normal controls (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 or <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). While the SIT values decreased in the DM-DED group compared to the DED group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), no significant differences were found in the values of other tear parameters. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The higher prevalence and increased severity of MGD was found in patients with both T2DM and DED compared to those only with DED. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry ChiCTR1800019939, date of registration December 9, 2018, prospectively registered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-023-02795-7","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T10:04:21Z","timestamp":1675159461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of meibomian gland dysfunction in type 2 diabetes with dry eye disease: a non-randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Qin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"2795_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2415-8-10","volume":"8","author":"MR Manaviat","year":"2008","unstructured":"Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC ophthalmo. 2008;8:10.","journal-title":"BMC ophthalmo"},{"key":"2795_CR2","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1167\/iovs.11-9228","volume":"53","author":"E Viso","year":"2012","unstructured":"Viso E, Rodriguez-Ares MT, Abelenda D, Oubina B, Gude F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 2012;53:2601\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2795_CR3","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1167\/iovs.10-6997d","volume":"52","author":"KB Green-Church","year":"2011","unstructured":"Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, Barabino S, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci. 2011;52:1979\u201393.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2795_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","volume":"52","author":"E Knop","year":"2011","unstructured":"Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the Meibomian gland. Invest Ophthalmol Vis Sci. 2011;52:1938\u201378.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2795_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/3047867","author":"X Lin","year":"2017","unstructured":"Lin X, Xu B, Zheng Y, Coursey TG, Zhao Y, Li J, et al. Meibomian gland dysfunction in type 2 diabetic patients. J Ophthalmol. 2017. https:\/\/doi.org\/10.1155\/3047867.","journal-title":"J Ophthalmol"},{"key":"2795_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.optom.2019.02.003","volume":"12","author":"GP Johanna","year":"2019","unstructured":"Johanna GP, Antonio LA, Andr\u00e9s GS. Correlation between type 2 diabetes, dry eye and Meibomian glands dysfunction. J Optom. 2019;12:256\u201362.","journal-title":"J Optom"},{"key":"2795_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4314\/ahs.v22i1.36","volume":"22","author":"EK Abu","year":"2022","unstructured":"Abu EK, Ofori AO, Boadi-Kusi SB, Ocansey S, Yankah RK, Kyei S, et al. Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana. Afr Health Sci. 2022;22:293\u2013302.","journal-title":"Afr Health Sci"},{"issue":"9","key":"2795_CR8","doi-asserted-by":"publisher","first-page":"762493","DOI":"10.3389\/fmed.2022.762493","volume":"5","author":"H Wu","year":"2022","unstructured":"Wu H, Fang X, Luo S, Shang X, Xie Z, Dong N, et al. Meibomian glands and tear film findings in type 2 diabetic patients: a cross-sectional study. Front Med (Lausanne). 2022;5(9):762493.","journal-title":"Front Med (Lausanne)"},{"key":"2795_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108522","author":"Q Yang","year":"2021","unstructured":"Yang Q, Li B, Sheng M. Meibum lipid composition in type 2 diabetics with dry eye. Exp Eye Res. 2021. https:\/\/doi.org\/10.1016\/j.exer.2021.108522.","journal-title":"Exp Eye Res"},{"key":"2795_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615\u201321.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 10","key":"2795_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/ICO.0000000000000570","volume":"34","author":"NS Abdelfattah","year":"2015","unstructured":"Abdelfattah NS, Dastiridou A, Sadda SR, Lee OL. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea. 2015;34(Suppl 10):48\u201352.","journal-title":"Cornea"},{"key":"2795_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clae.2011.08.003","volume":"35","author":"H Pult","year":"2012","unstructured":"Pult H, Riede-Pult BH. Non-contact meibography: keep it simple but effective. Cont Lens Anterior Eye. 2012;35:77\u201380.","journal-title":"Cont Lens Anterior Eye"},{"key":"2795_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","volume":"115","author":"R Arita","year":"2008","unstructured":"Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the Meibomian glands in a normal population. Ophthalmology. 2008;115:911\u20135.","journal-title":"Ophthalmology"},{"key":"2795_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/eye.1991.65","volume":"5","author":"AJ Bron","year":"1991","unstructured":"Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye. 1991;5:395\u2013411.","journal-title":"Eye"},{"key":"2795_CR15","first-page":"221","volume":"23","author":"MA Lemp","year":"1995","unstructured":"Lemp MA. Report of the national eye institute\/industry workshop on clinical trials in dry eye. CLAO J. 1995;23:221\u201332.","journal-title":"CLAO J"},{"key":"2795_CR16","doi-asserted-by":"crossref","unstructured":"Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop 2007. Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the international dry eye workshop. Ocul Surf. 2007;5:108 \u2013152.","DOI":"10.1016\/S1542-0124(12)70083-6"},{"key":"2795_CR17","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","volume":"52","author":"A Tomlinson","year":"2011","unstructured":"Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on Meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006\u201349.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2795_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/ICO.0b013e31818913b4","volume":"28","author":"CA Blackie","year":"2009","unstructured":"Blackie CA, Korb DR. Recovery time of an optimally secreting meibomian gland. Cornea. 2009;28:293\u20137.","journal-title":"Cornea"},{"key":"2795_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/ICO.0b013e3181ac9fd0","volume":"29","author":"CA Blackie","year":"2009","unstructured":"Blackie CA, Korb DR. The diurnal secretory characteristics in individual Meibomian glands. Cornea. 2009;29:34\u20138.","journal-title":"Cornea"},{"key":"2795_CR20","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1097\/ICO.0b013e3181814cff","volume":"27","author":"DR Korb","year":"2008","unstructured":"Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea. 2008;27:1142\u20137.","journal-title":"Cornea"},{"key":"2795_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ajo.2005.11.004","volume":"141","author":"M Yamaguchi","year":"2006","unstructured":"Yamaguchi M, Kutsuna M, Uno T, Zheng X, Kodama T, Ohashi Y. Marx line: fluorescein staining line on the inner lid as indicator of Meibomian gland function. Am J Ophthalmol. 2006;141:669\u201375.","journal-title":"Am J Ophthalmol"},{"key":"2795_CR22","doi-asserted-by":"publisher","first-page":"E760","DOI":"10.1097\/OPX.0b013e3182512ac1","volume":"89","author":"H Pult","year":"2012","unstructured":"Pult H, Nichols JJ. A review of meibography. Optom Vis Sci. 2012;89:E760\u20139.","journal-title":"Optom Vis Sci"},{"key":"2795_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clae.2012.10.074","volume":"36","author":"H Pult","year":"2013","unstructured":"Pult H, Riede-Puh BH. Comparison of subjective grading and objective assessment in Meibography. Contact Lens Anterior Eye. 2013;36:22\u20137.","journal-title":"Contact Lens Anterior Eye"},{"key":"2795_CR24","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.18240\/ijo.2019.09.07","volume":"12","author":"T Yu","year":"2019","unstructured":"Yu T, Han XG, Gao Y, Song AP, Dang GF. Morphological and cytological changes of Meibomian glands in patients with type 2 diabetes mellitus. Int J Ophthalmol. 2019;12:1415\u20139.","journal-title":"Int J Ophthalmol"},{"key":"2795_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jtos.2017.01.006","volume":"15","author":"G Geerling","year":"2017","unstructured":"Geerling G, Baudouin C, Aragona P, Rolando M, Boboridis KG, Ben\u00edtez-Del-Castillo JM, et al. Emerging strategies for the diagnosis and treatment of Meibomian gland dysfunction: proceedings of the OCEAN group meeting. Ocul Surf. 2017;15:179\u201392.","journal-title":"Ocul Surf"},{"key":"2795_CR26","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/ICO.0b013e3181d4f366","volume":"29","author":"CA Blackie","year":"2010","unstructured":"Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ. Nonobvious obstructive Meibomian gland dysfunction. Cornea. 2010;29:1333\u201345.","journal-title":"Cornea"},{"key":"2795_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajo.2019.09.005","volume":"209","author":"J Xiao","year":"2020","unstructured":"Xiao J, Adil MY, Chen X, Utheim \u00d8A, R\u00e6der S, T\u00f8nseth KA, et al. Functional and morphological evaluation of meibomian glands in the assessment of Meibomian gland dysfunction subtype and severity. Am J Ophthalmol. 2020;209:160\u20137.","journal-title":"Am J Ophthalmol"},{"key":"2795_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/ICO.0000000000000092","volume":"33","author":"Y Eom","year":"2014","unstructured":"Eom Y, Choi KE, Kang SY, Lee HK, Kim HM, Song JS. Comparison of Meibomian gland loss and expressed Meibum grade between the upper and lower eyelids in patients with obstructive Meibomian gland dysfunction. Cornea. 2014;33:448\u201352.","journal-title":"Cornea"},{"key":"2795_CR29","doi-asserted-by":"publisher","first-page":"E310","DOI":"10.1097\/OPX.0b013e318244e487","volume":"89","author":"H Pult","year":"2012","unstructured":"Pult H, Riede-Pult BH, Nichols JJ. Relation between upper and lower lids\u2019 Meibomian gland morphology, tear film, and dry eye. Optom Vis Sci. 2012;89:E310\u20135.","journal-title":"Optom Vis Sci"},{"key":"2795_CR30","doi-asserted-by":"publisher","first-page":"7814","DOI":"10.1167\/iovs.15-18049","volume":"56","author":"J Ding","year":"2015","unstructured":"Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human Meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015;56:7814\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2795_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.63.1.30","volume":"63","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zhang H, Zhao Z, Luo X, Zhang M, Bu J, et al. Hyperglycemia induces Meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2022;63:30.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2795_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bjophthalmol-2015-307369","volume":"100","author":"DL DeMill","year":"2016","unstructured":"DeMill DL, Hussain M, Pop-Busui R, Shtein RM. Ocular surface disease in patients with diabetic peripheral neuropathy. Br J Ophthalmol. 2016;100:924\u20138.","journal-title":"Br J Ophthalmol"},{"key":"2795_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/bjo.84.1.19","volume":"84","author":"M Goebbels","year":"2000","unstructured":"Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol. 2000;84:19\u201321.","journal-title":"Br J Ophthalmol"},{"key":"2795_CR34","doi-asserted-by":"publisher","first-page":"E96","DOI":"10.1111\/aos.12063","volume":"92","author":"H Lv","year":"2014","unstructured":"Lv H, Li A, Zhang X, Xu M, Qiao Y, Zhang J, et al. Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients. Acta Ophthalmol. 2014;92:E96\u2013104.","journal-title":"Acta Ophthalmol"},{"key":"2795_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/02713689609007622","volume":"15","author":"DA Sullivan","year":"1996","unstructured":"Sullivan DA, Edwards JA, Wickham LA, Pena JD, Gao J, Ono M, et al. Identification and endocrine control of sex steroid binding sites in the lacrimal gland. Curr Eye Res. 1996;15:279\u201391.","journal-title":"Curr Eye Res"},{"key":"2795_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/02713680903184268","volume":"34","author":"R Shetty","year":"2009","unstructured":"Shetty R, Saeed T, Rashed H, Adeghate E, Singh J. Effect of diabetes mellitus on acinar morphology, peroxidase concentration, and release in isolated rat lacrimal glands. Curr Eye Res. 2009;34:905\u201311.","journal-title":"Curr Eye Res"},{"key":"2795_CR37","doi-asserted-by":"publisher","first-page":"E7960","DOI":"10.1097\/MD.0000000000007960","volume":"96","author":"JH Qu","year":"2017","unstructured":"Qu JH, Tian L, Zhang XY, Sun XG. Early central and peripheral corneal microstructural changes in type 2 diabetes mellitus patients identified using in vivo confocal microscopy: A case-control study. Medicine (Baltimore). 2017;96:E7960.","journal-title":"Medicine (Baltimore)"},{"key":"2795_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/ICO.0000000000000163","volume":"33","author":"KA Beckman","year":"2014","unstructured":"Beckman KA. Characterization of dry eye disease in diabetic patients versus nondiabetic patients. Cornea. 2014;33:851\u20134.","journal-title":"Cornea"},{"key":"2795_CR39","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1167\/iovs.15-16609","volume":"56","author":"T Utsunomiya","year":"2015","unstructured":"Utsunomiya T, Nagaoka T, Hanada K, Omae T, Yokota H, Abiko A, et al. Imaging of the corneal subbasal whorl-like nerve plexus: more accurate depiction of the extent of corneal nerve damage in patients with diabetes. Invest Ophthalmol Vis Sci. 2015;56:5417\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2795_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/bjophthalmol-2014-306038","volume":"100","author":"MS Jiang","year":"2016","unstructured":"Jiang MS, Yuan Y, Gu ZX, Zhuang SL. Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta\u2014analysis. Br J Ophthalmol. 2016;100:9\u201314.","journal-title":"Br J Ophthalmol"},{"key":"2795_CR41","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bjophthalmol-2015-307369","volume":"100","author":"DL DeMill","year":"2016","unstructured":"DeMill DL, Hussain M, Pop-Busui R, Shtein RM. Ocular surface disease in patients with diabetic peripheral neuropathy. Br J Ophthalmol. 2016;100:924\u20138.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02795-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-02795-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02795-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T10:05:26Z","timestamp":1675159526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-02795-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-02795-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"assertion":[{"value":"10 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the medical ethics committee of the Yangpu Hospital, Tongji University School of Medicine, Shanghai, China, in accordance with the WMA Declaration of Helsinki. Written informed consent was obtained from each participant at the examination site.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}